Global Biotech Company To Open Manufacturing Facility In Frederick County

The County says it will generate 1500 new jobs by the end of 2022.




Frederick, Md (KM)_ A diagnostics manufacturing facility is coming to Frederick County. The County Executive’s Office has announced that Ellume will be opening its facility on Executive Court in the Progress Labs corporate park, occupying 180-thousand square feet. Ellume plans to invest $16-million in the new facility, creating 15-hundred new jobs by the end of 2022.

Ellume develops diagnostic solutions for infectious diseases, such as COVID-19.

“This is great news for Frederick County,” said County Executive Jan Gardner, in a statement. “Ellume is on the cutting edge, making products that help the work overcome this health pandemic. We are excited to welcome them to our thriving life science and biopharm family. Frederick County has delivered on our  fast track permitting process to accelerate this project so production can begin in the second half of 2021. Frederick County is a great place to do business.”

Based in East Brisbane in New South Wales, Australia, Ellume is a digital diagnostic company that develops, manufactures and commercializes high-performance, connected products for health care professionals and consumers. Its focus is on detecting common infectious diseases which affect the global population, according to the County Executive’s Office.

The company will produce tests for infectious diseases such as COVID-19. Ellume has developed a COVID-19 Home Test, which is the first rapid self-test to receive Emergency Use Authorization from the US Food and Drug Administration, according to a statement from the county

The Ellume COVID-19 Home Test was the first rapid self-test for the coronavirus to receive Emergency Use Authorization from the US Food and Drug Administration. The County Executive’s office says  it’s  for  those patients who have COVID but show no symptoms, and those who have the symptoms. This test kit is expected to play a major role as a screening tool for the coronavirus in the US.

“W look forward to building the foundation for Ellume’s long term vision in the US recruiting the highly skilled talent in Maryland’s Biotech Corridor needed to fuel the our flagship US facility,” said Jeff Boyle, PhD, Ellume’s US President, in a statement. ” Frederick is the ideal location for Ellume as we continue to work closely with the US Government in developing COVID-19 tests to communities across the country. The faculty will serve as a foundation for Ellume to support domestic response to the COVID-19 pandemic and better prepare the US for future public health crises.”

Ellume signed an agreement   in February, 2021 with the US Department of Defense in coordination with the Department of Health and Human Services to accelerate the manufacture of its COVID-19 home tests, and support the pandemic preparation in the US.


By Kevin McManus